Novel Coronavirus (SARS-CoV-2/COVID-19)
For three weeks, beginning May 4 and ending May 24, the Department of Health and Human Services said it delivered to states, territories and government agencies more than 12,000 cases of 40 vials each of remdesivir to help treat COVID-19 infections.
AHA voiced support for legislation that would provide an additional $2 billion for hospitals and other health care providers to expand broadband and telehealth services during the COVID-19 crisis through the Federal Communication Commission Rural Health Care Program.
The Small Business Administration (SBA) and the Department of the Treasury recently released two interim final rules that provide additional guidance to Paycheck Protection Program (PPP) lenders and borrowers. The guidance primarily relates to the rules and process for applying for loan forgiveness…
Franciscan Health worked with its community partners on educational kits to help thousands of families cope during the pandemic.
AHA letter to Rep. Eshoo expressing support of the Health Care Broadband Expansion During COVID-19 Act, which proposes improvements to the Federal Communications Commission (FCC) Rural Health Care Program.
AHA Expresses Support for the Health Care Broadband Expansion During COVID-19 Act, which proposes improvements to the Federal Communications Commission (FCC) Rural Health Care Program.
The Census Bureau recently reported that “a third of Americans now show signs of clinical anxiety or depression” due to the COVID-19 pandemic. It’s also been reported that Americans are increasingly at risk for “deaths of despair” from substance misuse and suicide, forecasting that the mental…
The COVID-19 pandemic has brought new challenges for health care providers, including the way teams communicate and work together.
FDA issued a reminder to health care facilities’ reprocessing staffs to follow the agency-outlined decontamination cycle when using the ASP STERRAD Sterilization System to decontaminate N95 or N95-equivalent respirators for reuse via vaporized hydrogen peroxide.
The FDA authorized the emergency use of certain personal protective equipment to help address insufficient supply due to the COVID-19 pandemic.